Autolus Therapeutics PLC (NAS:AUTL)
$ 3.92 0.05 (1.29%) Market Cap: 1.04 Bil Enterprise Value: 335.67 Mil PE Ratio: 0 PB Ratio: 1.79 GF Score: 55/100

Autolus Therapeutics plc - Special Call Transcript

Jun 01, 2020 / 12:30PM GMT
Release Date Price: $11.98 (-4.31%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Autolus Therapeutics ASCO AUTO3 Data Update Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today to Dr. Lucinda Crabtree, Vice President Investor Relations. Thank you. Please go ahead.

Lucinda Crabtree
Autolus Therapeutics plc - VP of IR & Corporate Communications

Thank you. Good morning or good afternoon, everyone, and thank you for taking part in today's call on the ASCO AUTO3 data update. I am Lucinda Crabtree, Vice President of Investor Relations. With me today are Dr. Christian Itin, our Chairman and Chief Executive Officer; Dr. Robert Chen, our AUTO3 and Lymphoma Program lead; Dr. Vijay Reddy, our Chief Medical Officer; Dr. Nushmia Khokhar, our Vice President of Clinical Development; Brent Rice, our Chief Commercial Officer in the U.S.; and Andrew Oakley, our Chief Financial Officer.

Before we begin, turning to Slide 2, I would

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot